

Lewy body dementia is a heterogeneous disease that is underdiagnosed and poorly understood. Pathologically, Lewy body dementia is characterised by the accumulation of intraneuronal aggregates of misfolded α-synuclein, known as Lewy bodies and Lewy neurites. The genetic architecture of Lewy body dementia is complex, involving both common genetic variants with small risk effects and rare genetic variants with large effects. Alzheimer's disease pathology frequently coexists with Lewy body pathology and influences the clinical presentation.
Neurology
|22nd Dec, 2025
|Journal of the American Medical Association
Neurology
|18th Dec, 2025
|Journal of the American Medical Association
Neurology
|17th Dec, 2025
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|The Lancet
Neurology
|15th Dec, 2025
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|Journal of the American Medical Association